Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cytek

Explore full profile

A leading manufacturer and supplier of flow cytometry products and services

Fremont, United StatesFounded 1992Biotech & Life Sciences
Valuation $503M Market cap · 2026
Revenue $100–500M Latest reported FY
EBITDA $88K Latest reported FY

About Cytek

Cytek Biosciences is a cell analysis solutions company that provides instruments, software, and services to the life sciences sector. The company's core technology is its proprietary Full Spectrum Profiling™ (FSP™), which is integrated into its flow cytometry instruments. These systems are designed to provide high-resolution and high-content cell analysis, enabling researchers and clinicians to obtain deeper insights from a single sample.

The company's product portfolio includes the Aurora and Northern Lights systems, which are full spectrum flow cytometers, and the Cytek Aurora CS, a cell sorter. To support its hardware, Cytek offers software for panel design and data analysis, such as the SpectroFlo® software and the Cytek Cloud platform. Its business model revolves around the sale of these instruments and related reagents, as well as providing technical support and training services.

Cytek serves a global market, with customers in academic research institutions, pharmaceutical and biotechnology companies, and clinical research organizations. The company is focused on applications in immunology, oncology, and cell biology, aiming to advance research in these fields.

Source: Dealroom company data

At a glance

Status
Listed
Founded
1992
Headquarters
Fremont, United States
Listing
IPO 2021
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series B and later6 investors entered at this stage

Employees mapped 444 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
23 countries with
team presence
🇺🇸 United States65.8%
🇨🇳 China5.7%
🇳🇱 Netherlands5.4%
🇩🇪 Germany3.9%
🇫🇷 France3.6%
Top 5 of 23 shown
Web traffic by country
79K monthly visits
across markets
🇺🇸 United States54.2%
🇨🇦 Canada5.2%
🏳️ Korea3.9%
🏳️ Republic of3.9%
🇩🇪 Germany3.2%
Top 5 markets shown

Patents

Estimated portfolio value
$24M

116 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cytek on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cytek on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.